Australia's Epsilon Healthcare soars on manufacturing deal for cannabis products

Epsilon Healthcare

21/10/2021 03:36

** Shares of Epsilon Healthcare  EPN.AX  rise as much as 32%
to A$0.165, post their sharpest intraday pct climb since Jan. 4,
2018
    ** Pharma co signs two-year agreement to manufacture
privately owned Cannim Australia's Jamaican cannabis products
 urn:newsml:reuters.com:*:nASX360cQw
    ** Under agreement, EPN's Southport facility will make the
products from Cannim's raw materials
    ** Co will receive payments from Cannim on a per-order basis
and expects such revenue inflows to be "material" to its
earnings 
    ** About 1.6 mln shares change hands, 5.6 times the 30-day
average volume of nearly 286,000 shares
    ** As of last close, stock down 46.8% this year

 (Reporting by Himanshi Akhand in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))